Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, sold RLAY on Jul 6, 2026
Data as of Oct 16
▼ SELL$331K17,717 shares at $18.69Thomas Catinazzo Chief Financial OfficerRLAY Relay Therapeutics, Inc.
- Traded
- Jul 6, 2026
- Disclosed
- Jul 8, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RLAY since disclosure
−17.1%
after the sale
Similar stocks (XLV) since disclosure
+8.9%
XLV — its sector index fund
Change in closing price from Jul 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.